“Generic medicines save lives by preventing, curing and managing non-communicable and communicable diseases for all Malaysians, especially the lower-income and marginalised groups,” opens the Malaysian AIDS Council (MAC)’s joint statement against the Trans-Pacific Partnership Agreement (TPPA), alongside five other signatories including the Positive Malaysian Treatment Access & Advocacy Group (MTAAG+).
The United States via the TPPA is demanding strict provisions that will reduce access to these affordable generic medicines. Of particular concern is Kaletra – a second line antri-retroviral for the management of HIV – that, while regularly prescribed by physicians and saves lives, are sadly “often out of reach of the pockets of persons living with HIV”.
MAC stands in opposition to any and all proposals that negatively affect access to medicines in the TPPA, and seeks the Malaysian government to reject patent extension provisions, data linkage, and border control measures that enable foreign customs officials to seize our medicines.
Read the joint statement in full here.